Congenital Conditions of Hypophosphatemia in Children

Erik Allen Imel1

  • 1Division of Endocrinology, Departments of Medicine and Pediatrics, Indiana University School of Medicine, 1120 West Michigan Street, Gatch Building Room 365, Indianapolis, IN, 46112, USA. eimel@iu.edu.

Insights

Hypophosphatemic disorders impair skeletal growth and function due to low phosphate levels. Understanding congenital causes leads to new treatments for rickets and osteomalacia.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Phosphate is vital for skeletal growth, DNA, RNA, and signaling pathways.
  • Hypophosphatemia affects multiple systems, causing nonspecific symptoms.
  • Chronic hypophosphatemia primarily impacts musculoskeletal function, leading to rickets and osteomalacia.

Purpose of the Study:

  • Review the pathophysiology of congenital hypophosphatemia.
  • Discuss clinical consequences of these disorders.
  • Outline current medical therapies.

Main Methods:

  • Literature review of pathophysiologic mechanisms.
  • Analysis of clinical manifestations.
  • Synthesis of therapeutic approaches.

Main Results:

  • Congenital conditions are the most common cause of hypophosphatemia in children.
  • Hypophosphatemia can cause significant growth impairment and bone disease.
  • Novel therapeutic strategies are emerging based on improved pathophysiologic understanding.

Conclusions:

  • Congenital hypophosphatemia requires comprehensive understanding for effective management.
  • Early diagnosis and treatment are crucial for mitigating long-term effects.
  • Advances in pathophysiology are driving innovative therapeutic interventions.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
627
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
14.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174